Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring

Cyclosporine (CyA) blood trough level (BTL), CyA dose pharmacokinetics, area under the curve (AUC), blood Cyclophylin (CyP) binding, and exposure index (EI) are often used as indicators of CyA efficacy and dose adjustment,1; 2 ; 3 despite conflicting results regarding their correlation with graft re...

Full description

Saved in:
Bibliographic Details
Main Author: Mokhbat, J. (author)
Other Authors: Kilani, H. (author), Barbari, A. (author), Masri, M. A. (author), Stephan, A. (author), Rizk, S. (author), Kamel, G. (author), Joubran, N. (author)
Format: article
Published: 2001
Online Access:http://hdl.handle.net/10725/5283
http://dx.doi.org/10.1016/S0041-1345(01)02190-X
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://ku7rj9xt8c.scholar.serialssolutions.com/?sid=google&auinit=A&aulast=Barbari&atitle=Cyclosporine+lymphocyte+versus+whole+blood+pharmacokinetic+monitoring:+correlation+with+histological+findings.&id=pmid:11498159
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513465773719552
author Mokhbat, J.
author2 Kilani, H.
Barbari, A.
Masri, M. A.
Stephan, A.
Rizk, S.
Kamel, G.
Joubran, N.
author2_role author
author
author
author
author
author
author
author_facet Mokhbat, J.
Kilani, H.
Barbari, A.
Masri, M. A.
Stephan, A.
Rizk, S.
Kamel, G.
Joubran, N.
author_role author
dc.creator.none.fl_str_mv Mokhbat, J.
Kilani, H.
Barbari, A.
Masri, M. A.
Stephan, A.
Rizk, S.
Kamel, G.
Joubran, N.
dc.date.none.fl_str_mv 2001
2017-02-27T13:57:46Z
2017-02-27T13:57:46Z
2017-02-27
dc.identifier.none.fl_str_mv 0041-1345
http://hdl.handle.net/10725/5283
http://dx.doi.org/10.1016/S0041-1345(01)02190-X
Barbari, A., Masri, M. A., Stephan, A., Mokhbat, J., Kilani, H., Rizk, S., ... & Joubran, N. (2001, August). Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings. In Transplantation proceedings 33(5), 2782-2785
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://ku7rj9xt8c.scholar.serialssolutions.com/?sid=google&auinit=A&aulast=Barbari&atitle=Cyclosporine+lymphocyte+versus+whole+blood+pharmacokinetic+monitoring:+correlation+with+histological+findings.&id=pmid:11498159
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Transplantation Proceedings
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
Correlation With Histological Findings
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Cyclosporine (CyA) blood trough level (BTL), CyA dose pharmacokinetics, area under the curve (AUC), blood Cyclophylin (CyP) binding, and exposure index (EI) are often used as indicators of CyA efficacy and dose adjustment,1; 2 ; 3 despite conflicting results regarding their correlation with graft rejection and CyA nephrotoxicity.4; 5; 6; 7; 8; 9 ; 10 CyA immunosuppressive effect is initiated by its binding to its lymphocyte (Lc) receptor, the CyP.11 ; 12 It would be, therefore, more advantageous to monitor CyA pharmacokinetics at the site of action with the Lc by measuring intra-lymphocytic CyA trough level (LTL). Recent studies have shown a good correlation between CyA-CyP binding and its in vitro immunosuppressive activity. 13 ; 14 We hypothesized that drug-receptor interaction measurement might reflect more accurately the concentrations of biologically relevant compounds and hence may provide a better correlation with clinical events. The aim of our study was to compare CyA LTL to CyA BTL and dose in relation to 1) histological findings in renal transplant patients with graft dysfunction and 2) total lymphocyte count, a reflector of the state of immunosuppression.
eu_rights_str_mv openAccess
format article
id LAURepo_d1f7a5debc2037643f602dda32cfe694
identifier_str_mv 0041-1345
Barbari, A., Masri, M. A., Stephan, A., Mokhbat, J., Kilani, H., Rizk, S., ... & Joubran, N. (2001, August). Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings. In Transplantation proceedings 33(5), 2782-2785
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/5283
publishDate 2001
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic MonitoringCorrelation With Histological FindingsMokhbat, J.Kilani, H.Barbari, A.Masri, M. A.Stephan, A.Rizk, S.Kamel, G.Joubran, N.Cyclosporine (CyA) blood trough level (BTL), CyA dose pharmacokinetics, area under the curve (AUC), blood Cyclophylin (CyP) binding, and exposure index (EI) are often used as indicators of CyA efficacy and dose adjustment,1; 2 ; 3 despite conflicting results regarding their correlation with graft rejection and CyA nephrotoxicity.4; 5; 6; 7; 8; 9 ; 10 CyA immunosuppressive effect is initiated by its binding to its lymphocyte (Lc) receptor, the CyP.11 ; 12 It would be, therefore, more advantageous to monitor CyA pharmacokinetics at the site of action with the Lc by measuring intra-lymphocytic CyA trough level (LTL). Recent studies have shown a good correlation between CyA-CyP binding and its in vitro immunosuppressive activity. 13 ; 14 We hypothesized that drug-receptor interaction measurement might reflect more accurately the concentrations of biologically relevant compounds and hence may provide a better correlation with clinical events. The aim of our study was to compare CyA LTL to CyA BTL and dose in relation to 1) histological findings in renal transplant patients with graft dysfunction and 2) total lymphocyte count, a reflector of the state of immunosuppression.PublishedN/A2017-02-27T13:57:46Z2017-02-27T13:57:46Z20012017-02-27Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article0041-1345http://hdl.handle.net/10725/5283http://dx.doi.org/10.1016/S0041-1345(01)02190-XBarbari, A., Masri, M. A., Stephan, A., Mokhbat, J., Kilani, H., Rizk, S., ... & Joubran, N. (2001, August). Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings. In Transplantation proceedings 33(5), 2782-2785http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://ku7rj9xt8c.scholar.serialssolutions.com/?sid=google&auinit=A&aulast=Barbari&atitle=Cyclosporine+lymphocyte+versus+whole+blood+pharmacokinetic+monitoring:+correlation+with+histological+findings.&id=pmid:11498159enTransplantation Proceedingsinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/52832021-03-19T10:03:22Z
spellingShingle Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
Mokhbat, J.
status_str publishedVersion
title Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
title_full Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
title_fullStr Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
title_full_unstemmed Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
title_short Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
title_sort Cyclosporine Lymphocyte Versus Whole Blood Pharmacokinetic Monitoring
url http://hdl.handle.net/10725/5283
http://dx.doi.org/10.1016/S0041-1345(01)02190-X
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://ku7rj9xt8c.scholar.serialssolutions.com/?sid=google&auinit=A&aulast=Barbari&atitle=Cyclosporine+lymphocyte+versus+whole+blood+pharmacokinetic+monitoring:+correlation+with+histological+findings.&id=pmid:11498159